Leading medical device company presents real-world use of InPen™ on glycemic and insulin design outcomes.
| CONTEXT: Amongst the 7 data presentations at this year’s American Diabetes Association meeting will be findings from a real-world study assessing the use of the Inpen™ device on patients with poorly controlled diabetes. This style of presentation is becoming the norm at congresses and conferences with real-world research and real-world data supporting the traditional pivotal studies designs for a great overall product impact. READ TIME: 2 mins 1. “Poster presentations will be available to all attendees for viewing with an option to query presenters throughout the conference. ” 2. “Medtronic will be participating in this year’s American Diabetes Association 81st Scientific Sessions virtual meeting. ” 3. “This year Medtronic will showcase its most advanced product portfolio designed to help individuals achieve better glucose control and spend less time managing highs and lows with the right solution, at the right time, no matter where an individual is on their journey with diabetes. ” 4. “The company’s full portfolio of diabetes technologies, spanning smart insulin pen system and advanced insulin pump technology like the MiniMed 770G and 780G systems.” Source URL: https://www.newswire.ca/news-releases/medtronic-announces-real-world-data-on-inpen-tm-and-extended-infusion-set-pivotal-trial-data-at-the-american-diabetes-association-81st-scientific-sessions-815627364.html |